301 results on '"Dumesic, Daniel A."'
Search Results
2. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome
3. Endocrine–metabolic dysfunction in polycystic ovary syndrome: an evolutionary perspective
4. Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome?
5. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming
6. Measures of Patient Dissatisfaction With Health Care in Polycystic Ovary Syndrome: Retrospective Analysis
7. Chapter 13 - Precision Nutrition in Female Reproductive Health
8. 22 - Polycystic Ovary Syndrome and Hyperandrogenic States
9. Developmental Programming: Impact of Prenatal Testosterone Excess on Steroidal Machinery and Cell Differentiation Markers in Visceral Adipocytes of Female Sheep
10. Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
11. An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome.
12. Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.
13. Ontogeny of the ovary in polycystic ovary syndrome
14. Use of fertility medications and cancer risk: a review and update
15. Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report
16. Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapy
17. Protein phospholipase C Zeta1 expression in patients with failed ICSI but with normal sperm parameters
18. Cumulus Cell Mitochondrial Resistance to Stress In Vitro Predicts Oocyte Development During Assisted Reproduction
19. Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep
20. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.
21. Contributors
22. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
23. Inflammatory Factors in Reproductive Medicine
24. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer
25. A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF)
26. The Physician Automobilist
27. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring
28. Impaired Preadipocyte Differentiation Into Adipocytes in Subcutaneous Abdominal Adipose of PCOS-Like Female Rhesus Monkeys
29. Intrauterine Environment and Polycystic Ovary Syndrome
30. 21-Hydroxylase-Derived Steroids in Follicles of Nonobese Women Undergoing Ovarian Stimulation for In Vitro Fertilization (IVF) Positively Correlate With Lipid Content of Luteinized Granulosa Cells (LGCs) as a Source of Cholesterol for Steroid Synthesis
31. Polycystic ovary syndrome and its developmental origins
32. Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys
33. Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation
34. Cancer risk and PCOS
35. Effects of Endogenous Androgens and Abdominal Fat Distribution on the Interrelationship Between Insulin and Non-Insulin-Mediated Glucose Uptake in Females
36. Regional uptake of meal fatty acids in humans
37. Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
38. Editorial
39. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
40. Chapter 21 - Polycystic Ovary Syndrome and Hyperandrogenic States
41. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
42. Developmental Programming: Excess Weight Gain Amplifies the Effects of Prenatal Testosterone Excess On Reproductive Cyclicity—Implication for Polycystic Ovary Syndrome
43. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone
44. Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women.
45. Plasma Free Fatty Acid Storage in Subcutaneous and Visceral Adipose Tissue in Postabsorptive Women
46. Implications of Polycystic Ovary Syndrome on Oocyte Development
47. Polycystic Ovary Syndrome and Oocyte Developmental Competence
48. Meal Fatty Acid Uptake in Visceral Fat in Women
49. Increased Adiposity Enhances Intrafollicular Estradiol Levels in Normoandrogenic Ovulatory Women Receiving Gonadotropin-Releasing Hormone Analog/Recombinant Human Follicle-Stimulating Hormone Therapy for in Vitro Fertilization
50. Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.